Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Validation of a novel therapeutic target for endothelial dysfunction: Regulation of endothelial nitric oxide synthase by Caveolin-1
FY 2009-10
Summary
Cardiovascular diseases refer to any disease that afflicts a part of the circulatory system, whether it be blood vessels or
the heart, such as atherosclerosis and hypertension. Cardiovascular disease is the leading cause of death and accounts
for approximately 19 billion in healthcare spending in Canada, or appoximately 12% of the total spent on all illnesses.
Decreases in protective nitric oxide within the body, produced by an enzyme called endothelial nitric oxide synthase
(eNOS), has been associated with many cardiovascular diseases. Research has shown that eNOS is inhibited by a
protein called caveolin-1 (Cav-1). This project contributes to our understanding of Cav-1 regulation of eNOS and may
shed some light on new disease treatment strategies and help us better understand the cause of many cardiovascular
diseases.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
201578
Name
Trane Andy
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Validation of a novel therapeutic target for endothelial dysfunction: Regulation of endothelial nitric oxide synthase by Caveolin-1
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Gst-Caveolin Pull Down; Nitric Oxide; Recombinant Caveolin-1; Velocity Gradient Centrifugation
Abstract
Cardiovascular diseases refer to any disease that afflicts a part of the circulatory system, whether it be blood vessels or
the heart, such as atherosclerosis and hypertension. Cardiovascular disease is the leading cause of death and accounts
for approximately 19 billion in healthcare spending in Canada, or appoximately 12% of the total spent on all illnesses.
Decreases in protective nitric oxide within the body, produced by an enzyme called endothelial nitric oxide synthase
(eNOS), has been associated with many cardiovascular diseases. Research has shown that eNOS is inhibited by a
protein called caveolin-1 (Cav-1). This project contributes to our understanding of Cav-1 regulation of eNOS and may
shed some light on new disease treatment strategies and help us better understand the cause of many cardiovascular
diseases.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Trane, Andy
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~